Simultaneous estimation of ceftazidime and ceftizoxime in pharmaceutical formulations by HPLC method

Basit Öğe Kaydı
dc.contributor.authorŞanlı, Senem
dc.contributor.authorŞanlı, Nurullah
dc.contributor.authorGümüştaş, Mehmet
dc.contributor.authorÖzkan, Sibel Ayşıl
dc.contributor.authorKaradaş, Nurullah
dc.contributor.authorAboul-Enein, Hassan Y.
dc.date.accessioned2019-05-10T09:38:50Z
dc.date.available2019-05-10T09:38:50Z
dc.date.issued2011
dc.departmentHitit Üniversitesi, Fen Edebiyat Fakültesi, Kimya Bölümü
dc.description.abstractThe aim of the present study was to develop a fast, sensitive and reliable method for rapid screening of cephalosporin injectable dosage forms namely ceftazidime and ceftizoxime to the detection of counterfeit and substandard drugs that might be illegally commercialized. Ceftazidime, ceftizoxime and cefixime (IS) were separated in a X-Terra RP-18 column (250 × 4.60 mm ID × 5 ?) and DAD detector set at 290 and 260 nm. The mobile phase consisted of a mixture of methanol:water 20:80 (v/v) at a flow rate of 1.0 mL min?1. Additionally, in order to find the optimum pH value of separation the pK a values of studied compounds were determined by using two different methodologies. Aqueous pK a values of studied compounds have been determined by UV-spectrophotometry and liquid chromatography were used for the determination and direct characterization of the dissociation constants by using the dependence of the capacity factor on the pH of the mobile phase in 20% (v/v) methanol–water binary mixture in which separation was performed. The pH of the mobile phase was adjusted with 25 mM H3PO4 to 3.2. The method was shown to be linear, sensible, accurate, and reproducible over the range of analysis and it can be used to pharmaceutical formulations containing a single active ingredient within a short analysis time.
dc.identifier.citationSanli, S., Sanli, N., Gumustas, M., Ozkan, S. A., Karadas, N., Aboul-Enein, H. Y. (2011). Simultaneous estimation of ceftazidime and ceftizoxime in pharmaceutical formulations by HPLC method. Chromatographia, 74(7-8), 549.
dc.identifier.doi10.1007/s10337-011-2116-1
dc.identifier.endpage558en_US
dc.identifier.issn0009-5893
dc.identifier.issue07.Augen_US
dc.identifier.scopusqualityQ3
dc.identifier.startpage549en_US
dc.identifier.urihttps://doi.org/10.1007/s10337-011-2116-1
dc.identifier.urihttps://hdl.handle.net/11491/500
dc.identifier.volume74en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.relation.ispartofChromatographia
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCeftazidimeen_US
dc.subjectCeftizoximeen_US
dc.subjectColumn Liquid Chromatographyen_US
dc.subjectPK A Valuesen_US
dc.subjectUV-Spectrophotometryen_US
dc.titleSimultaneous estimation of ceftazidime and ceftizoxime in pharmaceutical formulations by HPLC method
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu